Review| Volume 145, ISSUE 1, P3-8, July 2009

Download started.


Breast cancer: From the earliest times through to the end of the 20th century


      Breast cancer is a daunting disease and constitutes a continuing medical health problem through the ages for millions of women worldwide. Physicians, from the early periods of recorded history have tried to heal breast cancer patients, with results that were fairly promising at times and disappointing at others. The science of medicine evolved through the ages under the careful scrutiny and critical thought of the many prominent scholars and researchers of their times who constantly added to the therapeutic armamentarium. Surgeons described new therapeutic approaches, and anatomists, through their elaborate descriptions, added useful insights on the art of healing. Theories about the origin of cancer change as new scientific data are presented and validated. Although the Middle Ages hindered temporarily any progress in the field of medicine, the Renaissance became the vaulting horse for science in its broadest sense. However, it was not until the 19th century, with the discovery of anesthesia, the introduction of antisepsis, and the establishment of microscopy that giant scientific leaps in the field of breast cancer treatment occurred. The 20th century with the development of chemotherapy and radiation and the undertaking of numerous clinical trials offered new insights regarding breast cancer management. This article attempts a historical journey through the ages unfolding the problem of breast cancer through the different eras.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Cooper W.H.
        The history of the radical mastectomy.
        Ann Med Hist. 1941; 3: 36-54
        • Moulin D.
        A short history of breast cancer.
        Martinus Nijhoff Publ, Boston1983
        • Karpozilos A.
        • Pavlidis N.
        The treatment of cancer in Greek antiquity.
        Eur J Cancer. 2004; 40: 2033-2040
        • Mansfield C.M.
        Early breast cancer its history and results of treatment.
        Exp Biol Med. 1976; 5: 1-129
        • Harold E.
        A history of surgery.
        Grafos, Spain2001
      1. The contribution of French surgeons to wound healing in medieval and renaissance Europe. Dealy C. EWMA 2004;4:33–5.

      2. Wolff J. The science of cancerous disease from earliest times to the present. Canton: Science History Publications USA 1987;p. 3–45.

      3. Scultetus J. Armamentarium chirurgicum. Venetiis, Combi & La Nou 1665;p. 137.

      4. Wiseman R. Eight surgical treatises. London: B. Motte; 1734;p. 164, 320–32.

      5. Dionis P. Verhandeling van alle de chirurgicale operatien, na de nieuwste, zekerste, en gemakkelijkste manier. Rotterdam: Joannes Hoofhout, 1710.

      6. Rayter Z. Mansi J. History of breast cancer. Medical therapy of breast cancer. Cambridge University Press, Cambridge2003
        • Le Dran H.F.
        Memoire avec un précis de plusieurs#observations sur le cancer.
        Mem Acad Roy Chir. 1757; 3: 1-54
        • Haagensen C.D.
        Diseases of the breast.
        WB Saunders Co, Philadelphia1971 (p 394-395)
        • Pancoast J.
        A treatise on operative surgery.
        Carcy & Hart, Philadelphia1844
        • Paget J.
        On disease of the mammary areola preceding cancer of the mammary gland.
        St Bartholomew Hospital Rep. 1874; 10: 75-78
        • Moore C.
        On the influence of inadequate operations on the theory of cancer.
        F Med Chir Soc Lond. 1867; 1: 244-280
      7. Volkmann R. Beitrage zur Chirurgie, anschliessend an einen Bericht über die Tätigkeit der chirurgischen Universitätsklinik zur Halle im Jahre 1873. Leipzig: Breitkopff & Hartel, 1875;p 320–2.

      8. Gross SW. Tumors of the mammary gland. Philadelphia; 1850.

        • Halsted W.S.
        An improved method of the radical operation for carcinoma of the breast.
        Medical Record. 1894; 46: 746-748
        • Gocht H.
        Therapeutische Verwendung der Röntgenstrahlen.
        Fortschr Gebiete Röntgenstr. 1897; 1: 14-22
        • Steinthal C.
        Zur Dauerheilung des Brustkrebses.
        Beitr Klin Chir. 1905; 47: 226
        • Beatson G.T.
        On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases.
        Lancet. 1896; ii (104–7, 162–5)
        • Morrogh M.
        • Borgen P.I.
        • King T.A.
        The importance of local control in early-stage breast cancer: a historical review and a discussion of ongoing issues.
        Ann Surg Oncol. 2007; 14: 3310-3320
        • Huggins C.
        • Bergenstal D.M.
        Inhibition of human mammary and prostatic cancers by adrenalectomy.
        Cancer Res. 1952; 12: 134-141
        • Anonymous
        Sir Hugh Lett, BT (1876–1964).
        Br J Surg. 1964; 51: 799-801
        • Nathanson I.T.
        The effect of stilbestrol on advanced cancer of the breast.
        Cancer Res. 1946; 6: 484
        • Faloon W.W.
        • Owens L.A.
        • Broughton M.C.
        • Gorham L.W.
        The effect of testosterone on the pituitary-adrenal cortex mechanism in noncancerous and in breast cancer subjects.
        J Clin Endocrinol Metab. 1951; 11: 173-185
        • Jensen E.V.
        • DeSombre E.R.
        • Jungblut P.W.
        Estrogen receptors in hormone responsive tissues and tumors.
        in: Wissler R.W. Dao T.L. Wood Jr., S. Endogenous factors influencing host-tumor balance. University of Chicago Press, Chicago1967
        • Keynes G.L.
        The radium treatment of carcinoma of the breast.
        Br J Surg. 1932; 19: 415-480
        • Pfahler G.E.
        • Parry L.D.
        Rontgen therapy in carcinoma of the breast: a statistical study of 977 private cases.
        Ann Surg. 1931; 93: 412-427
        • Baclesse F.
        Five year results in 431 breast cancers treated solely by roentgen rays.
        Ann Surg. 1965; 161: 103-104
        • McWhirter R.
        Simple mastectomy and radiotherapy in the treatment of breast cancer.
        Br J Radiol. 1955; 28: 128
        • Handley W.S.
        Parasternal invasion of the thorax in breast cancer and its suppression by the use of radium tubes as an operative precaution.
        Surg Gynecol Obstet. 1927; 45: 721-782
        • Sugarbaker E.D.
        Radical mastectomy combined with in-continuity resection of the homolateral internal mammary node chain.
        Cancer. 1953; 6: 969-979
        • Dahl-Iversen E.
        • Tobiassen T.
        Radical mastectomy with parasternal and supraclavicular dissection for mammary carcinoma.
        Ann Surg. 1969; 170: 889-891
      9. Arhelger SW, Lewis FJ, Wangensteen OH. The extended or super-radical mastectomy for carcinoma of the breast. Surg Clin North Am 1956;1051–63.

        • Patey D.H.
        • Dyson W.H.
        The prognosis of carcinoma of the breast in relation of the type of operation performed.
        Br J Cancer. 1948; 2: 7-13
        • Auchincloss H.
        Modified radical mastectomy: why not?.
        Am J Surg. 1970; 119: 506-509
        • Crile Jr., G.
        Low incidence and morbidity of local recurrence after conservative operations for cancer of the breast.
        Ann Surg. 1972 Feb; 175: 249-253
        • Prudente A.
        Interscapulomammothoracic amputation.
        in: Treatment of cancer and allied diseases. vol. IV. Harper Company, New York, New York1964 (p. 133–42)
        • Atkins H.
        • Hayward J.L.
        • Klugman D.J.
        • Wayte A.B.
        Treatment of early breast cancer: a report after ten years of a clinical trial.
        Br Med J. 1972; 2: 423-429
        • Veronesi U.
        • Saccozzi R.
        • Del Vecchio M.
        • et al.
        Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast.
        N Engl J Med. 1981; 305: 6-11
        • Fisher B.
        • Redmond C.
        • Poisson R.
        • et al.
        Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer.
        N Engl J Med. 1989; 320: 822-828
      10. NIH Consensus Statement Online. Treatment of early-stage breast cancer; 1990 June 18–21 [cited 2007.11.01], 8. p. 1–19.

        • Chlebowski R.Y.
        • Hendrix S.L.
        • Langer R.D.
        • et al.
        Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.
        JAMA. 2003; 289: 3243-3253
        • Futreal P.A.
        • Liu Q.
        • Shattuck-Eidens D.
        • et al.
        BRCA1 mutations in primary breast and ovarian carcinomas.
        Science. 1994; 266: 120-122
        • Fisher B.
        • Constantino J.P.
        • Wickerham D.L.
        • et al.
        Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.
        J Natl Cancer Inst. 1998; 90: 1371-1388
        • Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
        Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
        Lancet. 2005; 365: 1687-1717
        • Viani G.A.
        • Afonso S.L.
        • Stefano E.J.
        • De Fendi L.I.
        • Soares F.V.
        Adjuvant trastuzumab in the treatment of her-2-positive early breast cancer: a meta-analysis of published randomized trials.
        BMC Cancer. 2007; 7: 153
        • Warner E.
        The role of magnetic resonance imaging in screening women at high risk of breast cancer.
        Top Magn Reson Imaging. 2008; 19: 163-169